Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
10/09/2018	19h58	Dow Jones News	Acorda Shares Tumble After Court Ruling	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/09/2018	18h41	PR Newswire (Canada)	Teva Canada annonce le lancement d'une version générique de (Pr)Abilify(MD) : les comprimés(Pr)Teva-Aripiprazole pour le t...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/09/2018	18h10	PR Newswire (Canada)	Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR)Teva-Aripiprazole Tablets for the treatment of Sc...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/09/2018	00h09	Dow Jones News	FDA Approves TEVA's Cassipa to Treat Opioid Dependence	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
06/09/2018	22h05	PR Newswire (US)	Teva, NACHC and Direct Relief Provide Important Insights on Prescription Medicine Access for Underserved Patients at the AAM ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
05/09/2018	22h11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/09/2018	17h44	Business Wire	Teva Announces $400 Million Debt Tender Offer	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
25/08/2018	15h29	Dow Jones News	EpiPen Shortage Hits Back-to-School Season	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/08/2018	23h54	Dow Jones News	Antares Pharma Shares Rise After FDA Approves First Rival Generic EpiPen	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/08/2018	14h06	Dow Jones News	Regeneron, Teva Report Positive Phase 3 Fasinumab Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/08/2018	13h00	Business Wire	Teva & Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/08/2018	13h00	PR Newswire (US)	Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of t...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
06/08/2018	14h00	Business Wire	Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/08/2018	15h39	Dow Jones News	Acorda Signs Settlement With Mylan on Generic Ampyra	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/08/2018	19h16	Dow Jones News	Teva Pharmaceutical's Sales Slump 18%	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/08/2018	13h00	Business Wire	Teva Reports Second Quarter 2018 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
25/07/2018	20h36	Dow Jones News	Acorda Shares Fall as Court Denies Injunction Request in Patent Case -- Market Mover	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
17/07/2018	14h30	Business Wire	Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/07/2018	02h05	Dow Jones News	FDA Recalls Several Medicines That Contain Valsartan	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/07/2018	14h00	Business Wire	Teva to Report Second Quarter 2018 Financial Results on August 2, 2018	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/07/2018	16h47	Business Wire	Teva Announces Launch of a Generic Version of Uceris® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/06/2018	23h06	Dow Jones News	ADRs End Higher	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/06/2018	14h00	Business Wire	Teva to Present New Fremanezumab Data, Including Long-Term Data, at the American Headache Society’s 60th Annual Scientific ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
15/06/2018	14h00	Business Wire	Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/05/2018	14h00	Business Wire	Teva Confirms September PDUFA Date for Fremanezumab	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
18/05/2018	23h10	Business Wire	CORRECTING & REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Epi...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/05/2018	00h53	Dow Jones News	Florida and Texas Are Among Latest States to Sue Opioid Painkiller Companies	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
15/05/2018	17h05	Business Wire	Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the J...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/05/2018	23h28	Dow Jones News	FDA Rejects Perrigo's ProAir Generic, Drug Maker Says	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/05/2018	15h21	PR Newswire (Canada)	Teva Canada annonce le lancement de l'émulsion ophtalmique Teva-Cyclosporine®, la première version générique de Restasis...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd